Masimo reported $7.57B in Market Capitalization this September of 2025, considering the latest stock price and the number of outstanding shares.


Market Capitalization Change Date
Abbott USD 236.64B 6.58B Jun/2025
Align Technology USD 13.72B 2.09B Jun/2025
AtriCure USD 1.62B 25M Jun/2025
Avanos Medical USD 566M 93M Jun/2025
Baxter International USD 15.54B 2.02B Jun/2025
Becton, Dickinson and Co. USD 49.37B 16.28B Jun/2025
Boston Scientific USD 158.91B 9.7B Jun/2025
Dexcom USD 34.23B 7.45B Jun/2025
Edwards Lifesciences USD 45.88B 3.27B Jun/2025
General Electric Aerospace USD 274.48B 61B Jun/2025
Globus Medical USD 7.99B 1.92B Jun/2025
Haemonetics USD 3.55B 352M Jun/2025
Insulet USD 22.11B 3.63B Jun/2025
Integra LifeSciences USD 954M 745M Jun/2025
Intuitive Surgical USD 194.77B 17.33B Jun/2025
Masimo USD 9.12B 118M Jun/2025
ResMed USD 37.83B 4.95B Jun/2025
Steris USD 23.63B 1.36B Jun/2025
Stryker USD 151.2B 8.94B Jun/2025
Tandem Diabetes Care USD 1.24B 33M Jun/2025
Teleflex USD 5.23B 940M Jun/2025
Thermo Fisher Scientific USD 154.12B 33.72B Jun/2025
Zimmer Biomet Holdings USD 18.05B 4.35B Jun/2025